
Niloofar Rahmani
Examiner (ID: 12602, Phone: (571)272-4329 , Office: P/1625 )
| Most Active Art Unit | 1625 |
| Art Unit(s) | 1625, 1691, 1621 |
| Total Applications | 2303 |
| Issued Applications | 1739 |
| Pending Applications | 128 |
| Abandoned Applications | 466 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 892276
[patent_doc_number] => 07345055
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2008-03-18
[patent_title] => 'Substituted C-imidazo [1,2-α] pyridin-3-yl-methylamines'
[patent_app_type] => utility
[patent_app_number] => 11/101471
[patent_app_country] => US
[patent_app_date] => 2005-04-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7553
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 17
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/345/07345055.pdf
[firstpage_image] =>[orig_patent_app_number] => 11101471
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/101471 | Substituted C-imidazo [1,2-α] pyridin-3-yl-methylamines | Apr 7, 2005 | Issued |
Array
(
[id] => 895479
[patent_doc_number] => 07342025
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2008-03-11
[patent_title] => 'Substituted C-imidazo[1,2-a]pyridin-3-yl-methylamines'
[patent_app_type] => utility
[patent_app_number] => 11/100535
[patent_app_country] => US
[patent_app_date] => 2005-04-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6957
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 17
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/342/07342025.pdf
[firstpage_image] =>[orig_patent_app_number] => 11100535
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/100535 | Substituted C-imidazo[1,2-a]pyridin-3-yl-methylamines | Apr 6, 2005 | Issued |
Array
(
[id] => 102370
[patent_doc_number] => 07728006
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2010-06-01
[patent_title] => 'Quinolinone-carboxamide compounds as 5-HT4 receptor agonists'
[patent_app_type] => utility
[patent_app_number] => 11/547790
[patent_app_country] => US
[patent_app_date] => 2005-04-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 25846
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 13
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/728/07728006.pdf
[firstpage_image] =>[orig_patent_app_number] => 11547790
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/547790 | Quinolinone-carboxamide compounds as 5-HT4 receptor agonists | Apr 5, 2005 | Issued |
Array
(
[id] => 6952919
[patent_doc_number] => 20050228014
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-10-13
[patent_title] => 'Quinolinone-carboxamide compounds as 5-HT4 receptor agonists'
[patent_app_type] => utility
[patent_app_number] => 11/100113
[patent_app_country] => US
[patent_app_date] => 2005-04-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 25859
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0228/20050228014.pdf
[firstpage_image] =>[orig_patent_app_number] => 11100113
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/100113 | Quinolinone-carboxamide compounds as 5-HT4 receptor agonists | Apr 5, 2005 | Issued |
Array
(
[id] => 267201
[patent_doc_number] => 07566727
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2009-07-28
[patent_title] => '2-(1-aza-bicyclo[2.2.2]oct-3-yl)-2,3-dihydro-isoindole-1-one/5,6-dihydro-furo[2,3-c] pyrrol-4-one derivative ligands for alpha 7 nicotinic acetylcholine receptor'
[patent_app_type] => utility
[patent_app_number] => 10/599839
[patent_app_country] => US
[patent_app_date] => 2005-04-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 20043
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 8
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/566/07566727.pdf
[firstpage_image] =>[orig_patent_app_number] => 10599839
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/599839 | 2-(1-aza-bicyclo[2.2.2]oct-3-yl)-2,3-dihydro-isoindole-1-one/5,6-dihydro-furo[2,3-c] pyrrol-4-one derivative ligands for alpha 7 nicotinic acetylcholine receptor | Apr 5, 2005 | Issued |
Array
(
[id] => 4705191
[patent_doc_number] => 20080064715
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-03-13
[patent_title] => '6-Azaindole Compound'
[patent_app_type] => utility
[patent_app_number] => 11/547308
[patent_app_country] => US
[patent_app_date] => 2005-04-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 54871
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0064/20080064715.pdf
[firstpage_image] =>[orig_patent_app_number] => 11547308
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/547308 | 6-azaindole compound | Apr 3, 2005 | Issued |
Array
(
[id] => 5895429
[patent_doc_number] => 20060003968
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-01-05
[patent_title] => 'Azaindoles useful as inhibitors of rock and other protein kinases'
[patent_app_type] => utility
[patent_app_number] => 11/098751
[patent_app_country] => US
[patent_app_date] => 2005-04-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 48741
[patent_no_of_claims] => 28
[patent_no_of_ind_claims] => 10
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0003/20060003968.pdf
[firstpage_image] =>[orig_patent_app_number] => 11098751
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/098751 | Azaindoles useful as inhibitors of rock and other protein kinases | Apr 3, 2005 | Issued |
Array
(
[id] => 7046146
[patent_doc_number] => 20050250741
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-11-10
[patent_title] => 'Novel indole derivatives as selective androgen receptor modulators (SARMS)'
[patent_app_type] => utility
[patent_app_number] => 11/096740
[patent_app_country] => US
[patent_app_date] => 2005-04-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 41228
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0250/20050250741.pdf
[firstpage_image] =>[orig_patent_app_number] => 11096740
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/096740 | Indole derivatives as selective androgen receptor modulators (SARMS) | Mar 31, 2005 | Issued |
Array
(
[id] => 74414
[patent_doc_number] => 07750020
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2010-07-06
[patent_title] => 'Sulfonamide-thiazolpyridine derivatives as glucokinase activators useful the treatment of Type 2 diabetes'
[patent_app_type] => utility
[patent_app_number] => 11/547046
[patent_app_country] => US
[patent_app_date] => 2005-04-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 23880
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/750/07750020.pdf
[firstpage_image] =>[orig_patent_app_number] => 11547046
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/547046 | Sulfonamide-thiazolpyridine derivatives as glucokinase activators useful the treatment of Type 2 diabetes | Mar 31, 2005 | Issued |
Array
(
[id] => 292406
[patent_doc_number] => 07544697
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2009-06-09
[patent_title] => 'Pyrazolopyridines and analogs thereof'
[patent_app_type] => utility
[patent_app_number] => 11/097715
[patent_app_country] => US
[patent_app_date] => 2005-04-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 127915
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 7
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/544/07544697.pdf
[firstpage_image] =>[orig_patent_app_number] => 11097715
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/097715 | Pyrazolopyridines and analogs thereof | Mar 31, 2005 | Issued |
Array
(
[id] => 5101935
[patent_doc_number] => 20070185197
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-08-09
[patent_title] => 'Phenol derivative, medicinal composition containing the same, and medicinal use thereof'
[patent_app_type] => utility
[patent_app_number] => 10/599444
[patent_app_country] => US
[patent_app_date] => 2005-03-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17589
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0185/20070185197.pdf
[firstpage_image] =>[orig_patent_app_number] => 10599444
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/599444 | Phenol derivative, medicinal composition containing the same, and medicinal use thereof | Mar 29, 2005 | Abandoned |
Array
(
[id] => 6967198
[patent_doc_number] => 20050234095
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-10-20
[patent_title] => 'Indazoles, benzothiazoles, benzoisothiazoles, benzisoxazoles, and preparation and uses thereof'
[patent_app_type] => utility
[patent_app_number] => 11/089533
[patent_app_country] => US
[patent_app_date] => 2005-03-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 54092
[patent_no_of_claims] => 45
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0234/20050234095.pdf
[firstpage_image] =>[orig_patent_app_number] => 11089533
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/089533 | Indazoles, benzothiazoles, benzoisothiazoles, benzisoxazoles, and preparation and uses thereof | Mar 24, 2005 | Abandoned |
Array
(
[id] => 7515410
[patent_doc_number] => 08039482
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2011-10-18
[patent_title] => 'Composition of solifenacin or salt thereof for use in solid formulation'
[patent_app_type] => utility
[patent_app_number] => 10/594127
[patent_app_country] => US
[patent_app_date] => 2005-03-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9660
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 87
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/08/039/08039482.pdf
[firstpage_image] =>[orig_patent_app_number] => 10594127
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/594127 | Composition of solifenacin or salt thereof for use in solid formulation | Mar 23, 2005 | Issued |
Array
(
[id] => 5829452
[patent_doc_number] => 20060063948
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-03-23
[patent_title] => 'Preparation of levulinic acid esters from alpha-angelica lactone and alcohols'
[patent_app_type] => utility
[patent_app_number] => 11/088115
[patent_app_country] => US
[patent_app_date] => 2005-03-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5558
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0063/20060063948.pdf
[firstpage_image] =>[orig_patent_app_number] => 11088115
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/088115 | Preparation of levulinic acid esters from alpha-angelica lactone and alcohols | Mar 22, 2005 | Abandoned |
Array
(
[id] => 411707
[patent_doc_number] => 07282509
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2007-10-16
[patent_title] => 'Stereoisomeric compounds and methods for the treatment of gastrointestinal and central nervous system disorders'
[patent_app_type] => utility
[patent_app_number] => 11/087167
[patent_app_country] => US
[patent_app_date] => 2005-03-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 3
[patent_no_of_words] => 18140
[patent_no_of_claims] => 58
[patent_no_of_ind_claims] => 10
[patent_words_short_claim] => 5
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/282/07282509.pdf
[firstpage_image] =>[orig_patent_app_number] => 11087167
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/087167 | Stereoisomeric compounds and methods for the treatment of gastrointestinal and central nervous system disorders | Mar 22, 2005 | Issued |
Array
(
[id] => 5120655
[patent_doc_number] => 20070142370
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-06-21
[patent_title] => 'Azabicyclooctan-3-one derivatives and use thereof'
[patent_app_type] => utility
[patent_app_number] => 10/590054
[patent_app_country] => US
[patent_app_date] => 2005-03-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 8455
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0142/20070142370.pdf
[firstpage_image] =>[orig_patent_app_number] => 10590054
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/590054 | Azabicyclooctan-3-one derivatives and use thereof | Mar 21, 2005 | Issued |
Array
(
[id] => 5160482
[patent_doc_number] => 20070173526
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-07-26
[patent_title] => 'Compounds and methods for treating dyslipidemia'
[patent_app_type] => utility
[patent_app_number] => 10/598473
[patent_app_country] => US
[patent_app_date] => 2005-03-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 28132
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0173/20070173526.pdf
[firstpage_image] =>[orig_patent_app_number] => 10598473
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/598473 | Compounds and methods for treating dyslipidemia | Mar 16, 2005 | Issued |
Array
(
[id] => 5189176
[patent_doc_number] => 20070167485
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-07-19
[patent_title] => 'Pyrazolo[3,4-b]pyridine compounds, and their use as pde4 inhibitors'
[patent_app_type] => utility
[patent_app_number] => 10/598944
[patent_app_country] => US
[patent_app_date] => 2005-03-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 34942
[patent_no_of_claims] => 27
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0167/20070167485.pdf
[firstpage_image] =>[orig_patent_app_number] => 10598944
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/598944 | Pyrazolo[3,4-b]pyridine compounds, and their use as PDE4 inhibitors | Mar 14, 2005 | Issued |
Array
(
[id] => 4910291
[patent_doc_number] => 20080021058
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-01-24
[patent_title] => 'Pyrazolo \'3,4-B! Pyridine Compounds And Their Use As Phosphodiesterase Type 4(Pde4) Inhibitors'
[patent_app_type] => utility
[patent_app_number] => 10/598940
[patent_app_country] => US
[patent_app_date] => 2005-03-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 25942
[patent_no_of_claims] => 39
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0021/20080021058.pdf
[firstpage_image] =>[orig_patent_app_number] => 10598940
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/598940 | Pyrazolo '3,4-B! Pyridine Compounds And Their Use As Phosphodiesterase Type 4(Pde4) Inhibitors | Mar 14, 2005 | Abandoned |
Array
(
[id] => 121808
[patent_doc_number] => 07709497
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2010-05-04
[patent_title] => 'Pyrazolo[3,4-b]pyridine compound, and its use as a PDE4 inhibitor'
[patent_app_type] => utility
[patent_app_number] => 10/598838
[patent_app_country] => US
[patent_app_date] => 2005-03-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 32683
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 22
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/709/07709497.pdf
[firstpage_image] =>[orig_patent_app_number] => 10598838
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/598838 | Pyrazolo[3,4-b]pyridine compound, and its use as a PDE4 inhibitor | Mar 14, 2005 | Issued |